Stoke Therapeutics shares are trading lower after the company announced the pricing of an upsized $125 million public offering of 5,555,557 common shares at $13.50 per share.

Stoke Therapeutics -3.40%

Stoke Therapeutics

STOK

15.07

-3.40%

Stoke Therapeutics shares are trading lower after the company announced the pricing of an upsized $125 million public offering of 5,555,557 common shares at $13.50 per share.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via